These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26296535)

  • 1. Qualitative patterns at Raven's colored progressive matrices in mild cognitive impairment and Alzheimer's disease.
    Ambra FI; Iavarone A; Ronga B; Chieffi S; Carnevale G; Iaccarino L; Cimminella F; Chiavazzo A; Garofalo E
    Aging Clin Exp Res; 2016 Jun; 28(3):561-5. PubMed ID: 26296535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and
    Yoshida T; Mori T; Shimizu H; Yoshino Y; Sonobe N; Matsumoto T; Kikuchi K; Miyagawa M; Iga J; Mochizuki T; Ueno SI
    Int J Geriatr Psychiatry; 2017 Apr; 32(4):407-413. PubMed ID: 27094214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ryu SY; Lee SB; Kim TW; Lee TJ
    Acta Neurol Belg; 2016 Dec; 116(4):535-541. PubMed ID: 26861053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncorrected errors and correct saccades in the antisaccade task distinguish between early-stage Alzheimer's disease dementia, amnestic mild cognitive impairment, and normal aging.
    Eraslan Boz H; Koçoğlu K; Akkoyun M; Tüfekci IY; Ekin M; Özçelik P; Akdal G
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2024 May; 31(3):457-478. PubMed ID: 37004192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free and Cued Selective Reminding Test is superior to the Wechsler Memory Scale in discriminating mild cognitive impairment from Alzheimer's disease.
    Lemos R; Cunha C; Marôco J; Afonso A; Simões MR; Santana I
    Geriatr Gerontol Int; 2015 Aug; 15(8):961-8. PubMed ID: 25243721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.
    Agostini S; Mancuso R; Baglio F; Cabinio M; Hernis A; Costa AS; Calabrese E; Nemni R; Clerici M
    Brain Behav Immun; 2016 Nov; 58():254-260. PubMed ID: 27470229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.
    Müller S; Preische O; Heymann P; Elbing U; Laske C
    J Alzheimers Dis; 2017; 55(4):1463-1469. PubMed ID: 27858717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment.
    Yoshino Y; Mori T; Yoshida T; Toyota Y; Shimizu H; Iga JI; Nishitani S; Ueno SI
    Clin Psychopharmacol Neurosci; 2017 Aug; 15(3):243-247. PubMed ID: 28783933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Scarabino D; Broggio E; Gambina G; Corbo RM
    Exp Gerontol; 2017 Nov; 98():143-147. PubMed ID: 28827085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clock drawing test in screening for Alzheimer's dementia and mild cognitive impairment in clinical practice.
    Vyhnálek M; Rubínová E; Marková H; Nikolai T; Laczó J; Andel R; Hort J
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):933-939. PubMed ID: 27466038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment due to alzheimer disease is less likely under the age of 65.
    Shin S; Kim JH; Cho JH; Kim GS; Choi SA; Lee JH;
    Alzheimer Dis Assoc Disord; 2015; 29(1):26-31. PubMed ID: 24759547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging.
    Li J; Broster LS; Jicha GA; Munro NB; Schmitt FA; Abner E; Kryscio R; Smith CD; Jiang Y
    Alzheimers Res Ther; 2017 Jan; 9(1):3. PubMed ID: 28100252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.